CJC-1295 without DAC
CND5
Lyophilized peptide for use under a licensed healthcare provider. Choose single ampule/vial or box of 10. Sourced via Ares Technology Limited (Hong Kong) / Healthtide Biotech manufacturing list dated 7 October 2026. Specification: 5 mg × 10 vials.
- • Prescription / clinician-supervised pathway
- • Same LIRAVEXIN cart and checkout as pen packages
- • Not medical advice — individual suitability is determined by your clinician
Clinical reference (clinician-supervised)
Investigational GH-axis support in adult clinic programs aiming to augment physiologic GH pulses. Not a first-line FDA-approved adult GH-deficiency therapy (those use rhGH or approved GHRH products where indicated).
No current FDA adult wellness label. Human CJC-1295 literature more clearly defines with-DAC pharmacokinetics; without-DAC clinic anecdotes often cite ~100 mcg SC once to several times daily—non-standardized. Clinician decides.
Often discussed as once daily to 1–3× daily SC in clinic anecdotes; not a labeled standard.
Subcutaneous.
Typical clinical / literature ranges under clinician supervision — not a prescription and not a DIY dosing guide. Individual dosing is determined solely by the treating clinician.
Liravexin USD for this pack (wholesale comparison · source × 3). Item is added to your shared cart for checkout coordination with your clinician pathway.
Or continue to checkout →